Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Pilot Clinical Study to Evaluate the Feasibility of Using the Single Patient Classifier as a Prognostic Test in Stage II-III Gastric Cancer Patients.

NCT06521528 is registered in ClinicalTrials.gov with Novomics. Co., Ltd. as lead sponsor.

NCT NCT06521528
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06521528 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Pilot Clinical Study to Evaluate the Feasibility of Using the Single Patient Classifier as a Prognostic Test in Stage II-III Gastric Cancer Patients.
Lead sponsor
Novomics. Co., Ltd.
Phase
Observational
Overall status
Unknown status
Start date
September 1, 2019
Completion date
December 31, 2025
Enrollment
237 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

gastric cancer